PR1 leukemia peptide vaccine
PR1 leukemia peptide vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.
PR1 leukemia peptide vaccine is under investigation in clinical trial NCT00513578 (Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome).
| Trade Name | PR1 leukemia peptide vaccine |
| Generic | PR1 leukemia peptide vaccine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here PR1 leukemia peptide vaccine
